Found 2 results
Filters: Author is A. Özgöz  [Clear All Filters]
H. Şamlı, Demir, B. Ç., Özgöz, A., Atalay, M. A., and Uncu, G., Vascular endothelial growth factor gene 1154 G/A, 2578 C/A, 460 C/T, 936 C/T polymorphisms and association with recurrent pregnancy losses, vol. 11, pp. 4739-4745, 2012.
Awata T, Inoue K, Kurihara S, Ohkubo T, et al. (2002). A common polymorphism in the 5'-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 51: 1635-1639. PMid:11978667   Bikfalvi A (2004). Recent developments in the inhibition of angiogenesis: examples from studies on platelet factor-4 and the VEGF/VEGFR system. Biochem. Pharmacol. 68: 1017-1021. PMid:15313395   Brogan IJ, Khan N, Isaac K, Hutchinson JA, et al. (1999). Novel polymorphisms in the promoter and 5' UTR regions of the human vascular endothelial growth factor gene. Hum. Immunol. 60: 1245-1249.   Carmeliet P, Ferreira V, Breier G, Pollefeyt S, et al. (1996). Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380: 435-439. PMid:8602241   Coulam CB and Jeyendran RS (2008). Vascular endothelial growth factor gene polymorphisms and recurrent pregnancy loss. Am. J. Reprod. Immunol. 59: 301-305. PMid:18294357   Ferrara N, Carver-Moore K, Chen H, Dowd M, et al. (1996). Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380: 439-442. PMid:8602242   Ferrara N, Gerber HP and LeCouter J (2003). The biology of VEGF and its receptors. Nat. Med. 9: 669-676. PMid:12778165   Harry LE and Paleolog EM (2003). From the cradle to the clinic: VEGF in developmental, physiological, and pathological angiogenesis. Birth Defects Res. C Embryo Today 69: 363-374. PMid:14745976   Hellgren M (1996). Hemostasis during pregnancy and puerperium. Haemostasis 26: 224-247.   Jin Q, Hemminki K, Enquist K, Lenner P, et al. (2005). Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis. Clin. Cancer Res. 11: 3647-3653. PMid:15897560   Krippl P, Langsenlehner U, Renner W, Yazdani-Biuki B, et al. (2003). A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk. Int. J. Cancer 106: 468-471. PMid:12845639   Lee HH, Hong SH, Shin SJ, Ko JJ, et al. (2010). Association study of vascular endothelial growth factor polymorphisms with the risk of recurrent spontaneous abortion. Fertil. Steril. 93: 1244-1247. PMid:19131057   Letsky EA and Swiet M (1994). Maternal Hemostasis: Coagulation Problems of Pregnancy. In: Thrombosis and Hemorrhage (Loscalzo J and Schafer AI, eds.). Blackwell Scientific Publications, Boston, 965-998.   Li TC, Makris M, Tomsu M, Tuckerman E, et al. (2002). Recurrent miscarriage: aetiology, management and prognosis. Hum. Reprod. Update 8: 463-481. PMid:12398226   Liu Q, Li Y, Zhao J, Sun DL, et al. (2009). Association of polymorphisms -1154G/A and -2578C/A in the vascular endothelial growth factor gene with decreased risk of endometriosis in Chinese women. Hum. Reprod. 24: 2660-2666. PMid:19531502   Mohammadi M, Ollier WE and Hutchinson IV (2003). A functional association study of VEGF gene promoter polymorphisms with VEGF expression by stimulated pbm cells. Hum. Immunol. 64 (Suppl 10): S125.   NCICB (2012). National Cancer Institute Web Services. Available at []. Accessed May 15, 2011.   Papazoglou D, Galazios G, Papatheodorou K, Liberis V, et al. (2005). Vascular endothelial growth factor gene polymorphisms and idiopathic recurrent pregnancy loss. Fertil. Steril. 83: 959-963. PMid:15820807   Regan L (1998). Overview of recurrent miscarriage. Gynaecol. Forum 3: 3-7.   Renner W, Kotschan S, Hoffmann C, Obermayer-Pietsch B, et al. (2000). A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J. Vasc. Res. 37: 443-448. PMid:11146397   Rowe AJ, Wulff C and Fraser HM (2003). Localization of mRNA for vascular endothelial growth factor (VEGF), angiopoietins and their receptors during the peri-implantation period and early pregnancy in marmosets (Callithrix jacchus). Reproduction 126: 227-238. PMid:12887279   Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, et al. (1995). Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376: 62-66. PMid:7596435   te Velde EA, Exalto N, Hesseling P and van der Linden HC (1997). First trimester development of human chorionic villous vascularization studied with CD34 immunohistochemistry. Hum. Reprod. 12: 1577-1581. PMid:9262300   Torry DS, Hinrichs M and Torry RJ (2004). Determinants of placental vascularity. Am. J. Reprod. Immunol. 51: 257-268. PMid:15212678   Watson CJ, Webb NJ, Bottomley MJ and Brenchley PE (2000). Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 12: 1232-1235. PMid:10930302   Wilcox AJ, Weinberg CR, O'Connor JF, Baird DD, et al. (1988). Incidence of early loss of pregnancy. N. Engl. J. Med. 319: 189-194. PMid:3393170   Yancopoulos GD, Davis S, Gale NW, Rudge JS, et al. (2000). Vascular-specific growth factors and blood vessel formation. Nature 407: 242-248. PMid:11001067   Yang B, Cross DF, Ollerenshaw M, Millward BA, et al. (2003). Polymorphisms of the vascular endothelial growth factor and susceptibility to diabetic microvascular complications in patients with type 1 diabetes mellitus. J. Diabetes Complications 17: 1-6.   Zygmunt M, Herr F, Munstedt K, Lang U, et al. (2003). Angiogenesis and vasculogenesis in pregnancy. Eur. J Obstet. Gynecol. Reprod. Biol. 110 (Suppl 1): S10-S18.